Previous close | 50.65 |
Open | 51.26 |
Bid | 52.47 x 800 |
Ask | 52.48 x 1200 |
Day's range | 51.13 - 52.69 |
52-week range | 38.48 - 61.71 |
Volume | |
Avg. volume | 28,040,577 |
Market cap | 294.507B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 14.99 |
EPS (TTM) | 3.50 |
Earnings date | 02 May 2022 - 06 May 2022 |
Forward dividend & yield | 1.60 (3.21%) |
Ex-dividend date | 12 May 2022 |
1y target est | 59.33 |
Shares of Pfizer (NYSE: PFE) were up 2.5% as of 11:35 a.m. ET on Friday after jumping as much as 4% earlier in the day. Meanwhile, the stocks of two other COVID-19 vaccine makers were declining. Moderna's (NASDAQ: MRNA) shares were down 4.7%.
Pfizer and Merck managed to gain solid upside momentum despite broad market pullback.
FDA grants emergency approval to Pfizer's COVID-19 vaccine for use in children 5- to 11-year old and approves Lilly's (LLY) novel diabetes treatment, Mounjaro (tirzepatide).